Product How it works Pricing Blog FAQ About Contact
Clariane

Clariane (EPA: CLARI) financial statements

The consolidated income statement, balance sheet and cash flow statement of Clariane for its last 6 fiscal years, as filed with the regulator, in millions of euros. At the end of fiscal 2025 it had €13,807m in total assets and €3,614m in equity.

Income statement

Item202520242023202220212020
Revenue€5,310m€5,282m€4,996m€4,438m€4,311m€3,874m
Operating profit€300.7m€262.0m€163.2m€272.5m€341.9m€265.9m
Profit before tax€11.9m−€36.7m−€76.2m€57.9m€131.9m€60.1m
Income tax−€3.3m−€9.4m−€2.6m€12.2m€13.5m€17.2m
Net profit€1.6m−€55.1m−€105.2m€22.1m€94.6m€39.4m
Earnings per share€0.004−€0.24−€0.99€0.21€0.90€0.43
Diluted earnings per share€0.004−€0.24−€0.89€0.13€0.73€0.30
Depreciation and amortisation——€693.2m€654.9m€615.8m—

Balance sheet

Item202520242023202220212020
Total assets€13,807m€14,261m€15,181m€14,574m€14,315m€13,197m
Current assets——€1,977m€1,788m€2,128m—
Inventories€36.2m€22.2m€28.3m€28.6m€28.2m€36.2m
Property, plant and equipment€2,886m€3,109m€3,144m€3,553m€3,078m€2,645m
Goodwill€3,130m€3,240m€3,288m€3,237m€3,214m€2,906m
Cash€784.8m€518.1m€677.9m€733.7m€1,215m€1,159m
Current liabilities———€2,823m€2,407m—
Equity€3,614m€3,692m€3,584m€3,539m€3,500m€3,157m
Equity including minorities€3,902m€4,021m€3,937m€3,868m€3,771m€3,323m
Minority interests€288.0m€328.5m€353.7m€328.7m€271.1m€165.6m

Cash flow statement

Item202520242023202220212020
Operating cash flow€1,072m€908.1m€793.2m€861.7m€853.9m€794.8m
Investing cash flow€137.6m€47.7m−€669.5m−€770.3m−€835.1m−€1,097m
Financing cash flow−€946.6m−€1,107m−€193.6m−€550.1m€27.4m€1,112m
Dividends paid€70.0m€50.8m€65.7m€57.8m€36.4m€10.2m

Where each figure comes from

From the annual report Clariane files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the Clariane page.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.